Stockreport

Tevogen.AI Head Discusses Company's Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference [Yahoo! Finance]

Tevogen Bio Holdings Inc.  (TVGN) 
PDF immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, highlights the commentary of Mit [Read more]